Qiao Cheng Selected Research

Focal Adhesion Kinase 2

4/2011	Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition.
1/2011	The role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinoma.
2/2010	Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
11/2008	Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
6/2008	The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiao Cheng Research Topics

Disease

14	Neoplasms (Cancer) 01/2018 - 11/2007
9	Hepatocellular Carcinoma (Hepatoma) 08/2014 - 11/2007
5	Virus Diseases (Viral Diseases) 01/2021 - 11/2016
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 02/2014
5	Neoplasm Metastasis (Metastasis) 08/2014 - 06/2008
3	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2017
2	Wounds and Injuries (Trauma) 10/2018 - 08/2014
2	Ischemia 12/2014 - 08/2012
2	Inflammation (Inflammations) 08/2014 - 08/2011
2	Reperfusion Injury 08/2014 - 08/2011
2	Necrosis 01/2012 - 01/2011
2	Liver Neoplasms (Liver Cancer) 02/2010 - 06/2008
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 02/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2022
1	Bronchiolitis Obliterans Syndrome 01/2021
1	Cytopenia 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Nijmegen Breakage Syndrome 06/2018
1	Anaplastic Thyroid Carcinoma 01/2018
1	RNA Virus Infections 01/2018
1	Disease Progression 01/2017
1	Blister (Bulla) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Fatty Liver 12/2014
1	Carcinogenesis 08/2010

Drug/Important Bio-Agent (IBA)

5	Antiviral Agents (Antivirals)IBA 01/2021 - 11/2016
5	Focal Adhesion Kinase 2IBA 04/2011 - 06/2008
4	Proteins (Proteins, Gene)FDA Link 06/2018 - 02/2010
3	Cisplatin (Platino)FDA LinkGeneric 08/2014 - 01/2011
2	ruxolitinibIBA 01/2021 - 01/2021
2	SteroidsIBA 01/2021 - 01/2021
2	CollagenIBA 10/2018 - 01/2017
2	Interleukin-17 (Interleukin 17)IBA 03/2018 - 04/2014
2	CytokinesIBA 01/2018 - 08/2014
2	Interferon Type IIBA 01/2018 - 01/2017
2	InterleukinsIBA 04/2014 - 08/2011
2	Interleukin-10 (Interleukin 10)IBA 08/2011 - 11/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2010 - 06/2008
1	Dimethyl FumarateIBA 02/2022
1	STAT1 Transcription FactorIBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Epirubicin (Ellence)FDA LinkGeneric 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	ZincIBA 10/2018
1	HydrogelsIBA 10/2018
1	Poly (ADP-Ribose) Polymerase-1IBA 06/2018
1	DNA (Deoxyribonucleic Acid)IBA 06/2018
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 06/2018
1	ChromatinIBA 06/2018
1	Deubiquitinating EnzymesIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	NADP (NADPH)IBA 01/2018
1	Phosphogluconate Dehydrogenase (Dehydrogenase, Phosphogluconate)IBA 01/2018
1	TNF Receptor-Associated Factor 3IBA 01/2018
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 04/2017
1	Phospholipases (Phospholipase)IBA 04/2017
1	EnzymesIBA 04/2017
1	Matrix Metalloproteinases (MMPs)IBA 04/2017
1	CateninsIBA 04/2017
1	UbiquitinIBA 01/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2015
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 11/2015
1	Lipocalin-2IBA 12/2014
1	Chemokine CXCL10IBA 12/2014
1	Messenger RNA (mRNA)IBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 08/2014
1	Angiopoietin-Like Protein 4IBA 08/2014
1	Chemotactic FactorsIBA 08/2014
1	Hemoglobins (Hemoglobin)IBA 08/2014
1	ChemokinesIBA 08/2014
1	Oxygen (Dioxygen)IBA 08/2014
1	Aldehyde Reductase (Aldose Reductase)IBA 08/2014
1	Bortezomib (Velcade)FDA Link 02/2014
1	Proteasome InhibitorsIBA 02/2014
1	X-Box Binding Protein 1IBA 08/2012
1	Activating Transcription Factor 6IBA 08/2012
1	4-phenylbutyric acid (Buphenyl)FDA Link 08/2012
1	Caspase 3 (Caspase-3)IBA 01/2012
1	S-allylcysteine (allyl cysteine)IBA 01/2012
1	Caspase 9IBA 01/2012
1	SB 216763IBA 08/2011
1	AtractylosideIBA 08/2011
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2011
1	Glycogen Synthase Kinase 3 betaIBA 08/2011
1	Focal Adhesion Protein-Tyrosine KinasesIBA 04/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2011
1	Small Interfering RNA (siRNA)IBA 08/2010

Therapy/Procedure

5	Liver Transplantation 01/2017 - 06/2008
4	Therapeutics 01/2021 - 08/2014
3	Drug Therapy (Chemotherapy) 01/2020 - 08/2014
2	Salvage Therapy 01/2021 - 01/2021
2	Immunotherapy 04/2014 - 11/2007
2	Warm Ischemia 08/2012 - 08/2011
1	Stem Cell Transplantation 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Transplantation 01/2021
1	TEC protocol 01/2020
1	Hepatectomy 12/2014
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2014